[1] de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol, 2022, 76(4):959-974.
[2] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 2017, 65(1):310-335.
[3] Villanueva C, Albillos A, Genescà J, et al.β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 2019, 393(10181):1597-1608.
[4] 黄晓铨,吴玲,姜思雨,等.食管静脉曲张出血的急诊内镜治疗选择与疗效评价.中国医师杂志,2022,24(5):653-657.
[5] Tseng Y, Ma L, Luo T, et al. Patient response to endoscopic therapy for gastroesophageal varices based on endoscopic ultrasound findings. Gut Liver, 2018, 12(5):562-570.
[6] 李冰,罗剑钧,张雯,等. 极高肝静脉压力梯度对食管胃静脉曲张二级预防患者内镜治疗短期预后的影响.中华消化杂志,2017,37(10):655-660.
[7] 黄晓铨,倪礼爰,姜思雨,等.门静脉血栓影响内镜治疗预防乙型肝炎肝硬化食管胃静脉曲张破裂再出血的疗效.中华肝脏病杂志,2020,28(9):747-752.
[8] 罗添成,黄晓铨,夏睿琦,等. 不明原因门脉高压食管胃静脉曲张患者的临床病理特征与内镜治疗.中国医师杂志,2021,23(3):324-327,332.
[9] Huang X, Li F, Wang L, et al. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer. Endoscopy, 2020, 52(9):727-735.
[10] Huang X, Zhang M, Ai Y, et al. Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Ther Adv Chronic Dis, 2022, 13:20406223221125691. |
